Esta página difunde información de la Asociación Mexicana de Bioseguridad, AC. (AMEXBIO) que es una organización de profesionales interesados en el manejo seguro del material biológicamente activo o infeccioso.



10.º Simposio Internacional de Bioseguridad
y Biocustodia (SIBB18)

Primer Simposio Iberoaméricano

en Puerto Vallarta, Jalisco.

5 al 8 de junio de 2018


Revista Mexicana de Bioseguridad

2014 (A)
2014 (B)
2012 (En Liderazgo y Experiencia Médica)
2011 (En Liderazgo y Experiencia Médica)

Lo más reciente de

  • Lessons to be Learned from...
    by (Julietta Torres) on December 14, 2017 at 3:00 pm

    During recent months, the Centers for Disease Control and Prevention (CDC) announced the occurrence of three major biosafety incidents, raising serious concern about biosafety and biosecurity guideline implementation in the most prestigious agencies in the United States: the CDC, the National Institutes of Health (NIH) and the Federal Drug Administration (FDA). These lapses included: a) the mishandling of Bacillus anthracis spores potentially exposing dozens of employees to anthrax; b) the shipment of low pathogenic influenza virus unknowingly cross-contaminated with a highly pathogenic strain; and c) an inventory lapse of hundreds of samples of biological agents, including six vials of variola virus kept in a cold storage room for decades, unnoticed. In this review we present the published data on these events, report the CDC inquiry's main findings, and discuss the key lessons to be learnt to ensure safer scientific practice in biomedical and microbiological service and research laboratories. REFERENCE: Weiss S, Yitzhaki S, Shapira SC. Lessons to be Learned from Recent Biosafety Incidents in the United States. Isr Med Assoc J. 2015 May;17(5):269-73. Review. PubMed PMID: 26137650. ----------------------------------------------------------- Sigue este Blog en Facebook y Twitter Ayúdanos a traducir las fichas de seguridad de microorganismos. […]

  • Enhancing Surveillance and...
    by (Julietta Torres) on December 11, 2017 at 3:00 pm

    Naturally occurring anthrax disproportionately affects the health and economic welfare of poor, rural communities in anthrax-endemic countries. However, many of these countries have limited anthrax prevention and control programs. Effective prevention of anthrax outbreaks among humans is accomplished through routine livestock vaccination programs and prompt response to animal outbreaks. The Centers for Disease Control and Prevention uses a 2-phase framework when providing technical assistance to partners in anthrax-endemic countries. The first phase assesses and identifies areas for improvement in existing human and animal surveillance, laboratory diagnostics, and outbreak response. The second phase provides steps to implement improvements to these areas. We describe examples of implementing this framework in anthrax-endemic countries. These activities are at varying stages of completion; however, the public health impact of these initiatives has been encouraging. The anthrax framework can be extended to other zoonotic diseases to build on these efforts, improve human and animal health, and enhance global health security. REFERENCE: Vieira, Antonio R. et al. “Enhancing Surveillance and Diagnostics in Anthrax-Endemic Countries.” Emerging Infectious Diseases 23.Suppl 1 (2017): S147–S153. PMC. Web. 9 Dec. 2017. ----------------------------------------------------------- Sigue este Blog en Facebook y Twitter Ayúdanos a traducir las fichas de seguridad de microorganismos. […]

  • Shelf-Life of Chlorine...
    by (Julietta Torres) on December 4, 2017 at 3:00 pm

    In Ebola Virus Disease (EVD) outbreaks, it is widely recommended to wash living things (handwashing) with 0.05% (500 mg/L) chlorine solution and non-living things (surfaces, personal protective equipment, dead bodies) with 0.5% (5,000 mg/L) chlorine solution. Chlorine solutions used in EVD response are primarily made from powdered calcium hypochlorite (HTH), granular sodium dichloroisocyanurate (NaDCC), and liquid sodium hypochlorite (NaOCl), and have a pH range of 5–11. Chlorine solutions degrade following a reaction highly dependent on, and unusually sensitive to, pH, temperature, and concentration. We determined the shelf-life of 0.05% and 0.5% chlorine solutions used in EVD response, including HTH, NaDCC, stabilized NaOCl, generated NaOCl, and neutralized NaOCl solutions. Solutions were stored for 30 days at 25, 30, and 35°C, and tested daily for chlorine concentration and pH. Maximum shelf-life was defined as days until initial concentration fell to <90% of initial concentration in ideal laboratory conditions. At 25–35°C, neutralized-NaOCl solutions (pH = 7) had a maximum shelf-life of a few hours, NaDCC solutions (pH = 6) 2 days, generated NaOCl solutions (pH = 9) 6 days, and HTH and stabilized NaOCl solutions (pH 9–11) >30 days. Models were developed for solutions with maximum shelf-lives between 1–30 days. Extrapolating to 40°C, the maximum predicted shelf-life for 0.05% and 0.5% NaDCC solutions were 0.38 and 0.82 hours, respectively; predicted shelf-life for 0.05% and 0.5% generated NaOCl solutions were >30 and 5.4 days, respectively. Each chlorine solution type offers advantages and disadvantages to responders, as: NaDCC is an easy-to-import high-concentration effervescent powder; HTH is similar, but forms a precipitate that may clog pipes; and, NaOCl solutions can be made locally, but are difficult to transport. We recommend responders chose the most appropriate source chlorine compound for their use, and ensure solutions are stored at appropriate temperatures and used or replaced before expiring. REFERENCIA: Iqbal, Qais et al. “Shelf-Life of Chlorine Solutions Recommended in Ebola Virus Disease Response.” Ed. Vincent Jacobus Munster. PLoS ONE 11.5 (2016): e0156136. ----------------------------------------------------------- Sigue este Blog en Facebook y Twitter Ayúdanos a traducir las fichas de seguridad de microorganismos. […]

  • Enterococcus hirae biofilm...
    by (Julietta Torres) on November 30, 2017 at 5:39 pm

    BACKGROUND: Nowadays, the bacterial contamination in the hospital environment is of particular concern because the hospital-acquired infections (HAIs), also known as nosocomial infections, are responsible for significant morbidity and mortality. This work evaluated the capability of Enterococcus hirae to form biofilm on different surfaces and the action of two biocides on the produced biofilms. METHODS: The biofilm formation of E. hirae ATCC 10541 was studied on polystyrene and stainless steel surfaces through the biomass quantification and the cell viability at 20 and 37 °C. The effect of LHIDROXI FAST and LH ENZYCLEAN SPRAY biocides on biomasses was expressed as percentage of biofilm reduction. E. hirae at 20 and 37 °C produced more biofilm on the stainless steel in respect to the polystyrene surface. The amount of viable cells was greater at 20 °C than with 37 °C on the two analyzed surfaces. Biocides revealed a good anti-biofilm activity with the most effect for LH ENZYCLEAN SPRAY on polystyrene and stainless steel at 37 °C with a maximum biofilm reduction of 85.72 and 86.37%, respectively. RESULTS: E. hirae is a moderate biofilm producer depending on surface material and temperature, and the analyzed biocides express a remarkable antibiofilm action. CONCLUSION: The capability of E. hirae to form biofilm can be associated with its increasing incidence in hospital-acquired infections, and the adoption of suitable disinfectants is strongly recommended. REFERENCIA: Di Lodovico S, et al. Enterococcus hirae biofilm formation on hospital material surfaces and effect of new biocides. Environ Health Prev Med. 2017 Aug 2;22(1):63. doi: 10.1186/s12199-017-0670-3. PubMed PMID: 29165147; PubMed Central PMCID: PMC5664585. ----------------------------------------------------------- Sigue este Blog en Facebook y Twitter Ayúdanos a traducir las fichas de seguridad de microorganismos. […]

  • Guidance on regulations for...
    by (Julietta Torres) on November 8, 2017 at 3:00 pm

    This publication provides information for identifying, classifying, marking, labelling, packaging, documenting and refrigerating infectious substances for transportation and ensuring their safe delivery. The document provides practical guidance to facilitate compliance with applicable international regulations for the transport of infectious substances by all modes of transport, both nationally and internationally, and include the changes that apply from 1 January 2017. The current revision replaces the document issued by the World Health Organization (WHO) in 2015 (document WHO/HSE/GCR/2015.2). This publication, however, does not replace national and international transport regulations. Applicable as from 1 January 2017 Authors:World Health Organization Publication details Number of pages: 40Publication date: 2017Languages: EnglishWHO reference number: WHO/WHE/CPI/2017.8 Downloads ==> English pdf 1.63 MB <==  ----------------------------------------------------------- Sigue este Blog en Facebook y Twitter Ayúdanos a traducir las fichas de seguridad de microorganismos. […]

Agradecemos a nuestro patrocinador platino 2017



Agradecemos a nuestros patrocinadores 2017